Development of a therapy-related psychological burden scale in oral immunotherapy for food allergy and relationship between stress and the outcome

2023 Fiscal Year Final Research Report

• Project/Area Number: 19K14042
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 08030:Family and consumer sciences, and culture and living-related
• Research Institution: Mukogawa Women's University
• Principal Investigator: Maeta Akihiro 武庫川女子大学, 食物栄養科学部, 講師 (30735014)
• Project Period (FY): 2019-04-01 – 2024-03-31
• Keywords: 食物アレルギー / 経口免疫療法 / 負担感 / COVID-19

Outline of Final Research Achievements

Treatment for allergic diseases such as food allergies takes a long time, and psychological factors of the patient and their guardian are deeply involved in the continuation of treatment. Therefore, this study attempted to develop a scale for parents' burden caused by the impact of the spread of COVID-19 and oral immunotherapy, which requires long-term intake.
The spread of COVID-19 has affected parents' behavior when seeking medical treatment. The psychological characteristics of parents who are easily affected have also been clarified. The Oral Immunotherapy Parental Burden Scale (OIT-PB) consists of 16 items and includes four subscales.
In the future, we aim to analyze factors affecting allergy treatment from multiple perspectives and improve treatment adherence.

Free Research Field

食物アレルギー

Academic Significance and Societal Importance of the Research Achievements

パンデミックが発生した場合の患児やその保護者の影響を把握することは，特殊な状況における医療従事者の対応の指針となりえる。本研究成果より，医者や医療機関は正しい状況を発信すること，影響されやすい保護者への支援が必要なことなどが示された。
経口免疫療法による保護者負担感尺度 (OIT-PB) は，患児の保護者の潜在的な心理的負担を見つけることに役立つと思われる。また，この尺度は栄養食事指導を受けている児の保護者に活用できると期待される。